Analysts' average 12-month price target for Smith & Nephew plc is $31.
Get informed when a big investor buys or sells
+ Follow$30.19
2 analysts in the last 4 months
High: $31.85 | Low: $30
No recommendations in the last 4 months.
Smith & Nephew plc's target price stands at $31. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
The Street's average target of $31 for SNN implies 2.4% upside versus today's price ($30.19). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.
The history chart shows how Smith & Nephew plc's target price evolved across reporting periods, while the comparison chart places SNN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, target price is commonly used to spot outliers. Smith & Nephew plc's reading of $31 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.